ArticleJournal of experimental & clinical cancer research : CR2019

Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.

Jiaojiao Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.